Micell Technologies: Clinical Trials

2 trials sponsored by Micell Technologies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Micell Technologies: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease
MiStent DES, Endeavor DES - Coronary Artery Disease
Phase 2CompletedMicell Technologies1842011-02-012017-02-08
First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery Disease
MiStent SES - Coronary Artery Disease
Phase 2CompletedMicell Technologies302010-11-012016-12-19

Conditions studied

Coronary Artery Disease (2)

Countries

Belgium (2)  ·  New Zealand (2)  ·  Australia (1)  ·  France (1)  ·  Netherlands (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

William Wijns, MD (2)  ·  John Ormiston, MD (1)

Results publications

PMID 23992957, PMID 24055443, PMID 24801119, PMID 25044635